HPV therapeutic vaccine phase III clinical trial unblinding, Jincheng Pharm's invested company achieves key breakthrough in women's health field同壁财经·May 20 at 09:56 PM300233+1.99%
A-share Three Major Indices Fell Collectively, Computing Hardware Active Against the Trend, Hang Seng Tech Index Down Over 1%, AI Large Model Stocks Rebound, KNOWLEDGE ATLAS Rises 7%Wallstreetcn·Apr 9 at 03:19 AM02513-0.86%002793-0.63%
Jincheng Pharm: Subsidiary products are expected to be selected for the 11th batch of national centralized drug procurementZhitong·Oct 28, 2025 at 08:15 AM300233+1.99%
Jincheng Pharm: Morphine Nitrazepam Sodium Injection has obtained a drug registration certificateZhitong·Oct 20, 2025 at 04:05 AM300233+1.99%
Jincheng Pharm: Subsidiary receives approval notice for drug supplementary applicationZhitong·Oct 17, 2025 at 03:06 AM300233+1.99%
A-share innovative drug concept stocks fluctuated lower, with BETTA PHARMACEUTICALS falling over 10%, Jincheng Pharm, Konruns, Baillie Tianheng, Olymvax Biopharmaceuticals, and CCHT all dropping more than 5%Zhitong·Oct 14, 2025 at 01:11 AM300233+1.99%000661+1.97%
The actual controller of Jincheng Pharm received a notice of administrative penalty in advanceZhitong·Oct 9, 2025 at 04:48 AM300233+1.99%
Jincheng Pharm: Klibor has obtained approval for the listing application of chemical raw materialsZhitong·Oct 9, 2025 at 04:21 AM300233+1.99%
Jincheng Pharm: Mirabegron has obtained approval for the listing application of chemical raw materialsZhitong·Sep 23, 2025 at 03:19 AM300233+1.99%
Jincheng Pharm: The company is collaborating with Heze Pharma on project cooperation in the field of women's healthZhitong·Aug 24, 2025 at 08:37 PM300233+1.99%
Jincheng Pharm released its performance for the first half of the year, with a net profit attributable to the parent company of 43.3832 million yuan, a year-on-year decrease of 66.78%Zhitong·Aug 20, 2025 at 08:10 AM300233+1.99%
Jincheng Pharm: The listing application for lactose acid erythromycin chemical raw materials has been approvedZhitong·Aug 5, 2025 at 04:33 AM300233+1.99%
Jincheng Pharm: Subsidiary "Progesterone Cream" has obtained import approval for pharmaceuticals in South KoreaZhitong·Jul 31, 2025 at 04:47 AM300233+1.99%
Jincheng Pharm's subsidiary has obtained the European Pharmacopoeia suitability certificate for Oseltamivir phosphate chemical raw materialsZhitong·Jul 28, 2025 at 06:34 AM300233+1.99%
Jincheng Pharm's subsidiary has renewed and changed the production enterprise license for tobacco monopoly, with the approved production capacity for nicotine used in e-cigarettes increased to no more than 200 tons/yearZhitong·Jul 17, 2025 at 10:58 PM300233+1.99%
